Does TOPOTECAN Cause Small cell lung cancer? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Small cell lung cancer have been filed in association with TOPOTECAN (HYCAMTIN). This represents 0.4% of all adverse event reports for TOPOTECAN.
13
Reports of Small cell lung cancer with TOPOTECAN
0.4%
of all TOPOTECAN reports
9
Deaths
6
Hospitalizations
How Dangerous Is Small cell lung cancer From TOPOTECAN?
Of the 13 reports, 9 (69.2%) resulted in death, 6 (46.2%) required hospitalization, and 2 (15.4%) were considered life-threatening.
Is Small cell lung cancer Listed in the Official Label?
Yes, Small cell lung cancer is listed as a known adverse reaction in the official FDA drug label for TOPOTECAN.
What Other Side Effects Does TOPOTECAN Cause?
Febrile neutropenia (425)
Off label use (390)
Death (332)
Product use in unapproved indication (323)
Neutropenia (255)
Pyrexia (252)
Anaemia (242)
Malignant neoplasm progression (238)
Drug ineffective (216)
Disease progression (207)
What Other Drugs Cause Small cell lung cancer?
CARBOPLATIN (74)
TARLATAMAB-DLLE (66)
ETOPOSIDE (65)
ATEZOLIZUMAB (62)
OSIMERTINIB (46)
METHOTREXATE (35)
AFATINIB (30)
ADALIMUMAB (29)
GEFITINIB (28)
NINTEDANIB (28)
Which TOPOTECAN Alternatives Have Lower Small cell lung cancer Risk?
TOPOTECAN vs TOPOTECAN\TOPOTECAN
TOPOTECAN vs TOPROL
TOPOTECAN vs TOREMIFENE
TOPOTECAN vs TORIPALIMAB
TOPOTECAN vs TORSEMIDE